SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-583103
Filing Date
2016-05-09
Accepted
2016-05-09 11:09:47
Documents
72
Period of Report
2016-05-09

Document Format Files

Seq Description Document Type Size
1 6-K d172918d6k.htm 6-K 684687
  Complete submission text file 0001193125-16-583103.txt   7291946

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT teva-20160331.xml EX-101.INS 1424187
3 XBRL TAXONOMY EXTENSION SCHEMA teva-20160331.xsd EX-101.SCH 151496
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20160331_cal.xml EX-101.CAL 111887
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20160331_def.xml EX-101.DEF 548529
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20160331_lab.xml EX-101.LAB 905663
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20160331_pre.xml EX-101.PRE 894969
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-16174 | Film No.: 161630404
SIC: 2834 Pharmaceutical Preparations